THURSDAY, Dec. 7, 2023 (HealthDay News) — A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with type 1 diabetes maintain their natural ability to produce insulin,Continue Reading